GSK Stock Recovers, Rises Around 17% YTD: Time to Buy, Sell or Hold?
We suggest that investors who own GSK's stock remain invested for now, considering its sales and profits are expected to continue improving in the coming years.
Investor's Business Daily on MSN9h
Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?
Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock a sell?
New Telegraph16h
Pharma W’Africa Pushes For Local Drug Production, Reduced Importation
ShareThe Pharma West Africa Conference and Exhibition focused on boosting medicine production in Nigeria and cutting down reliance on imported drugs, said Pharmacist Ahmad Ibrahim Yakasai, former ...
U.S. boosts bird flu response with another $100M in funds
In February, Turkey agreed to send more eggs to the U.S., where there is an ongoing shortage amid the death of nearly 170M ...
Medscape11h
Upadacitinib Dosing for AD Can Be Increased or Decreased Depending on Response
A treat-to-target study of upadacitinib in atopic dermatitis showed that dosing can be adjusted depending on early patient response without serious adverse effects.